Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group

The authors discuss humoral immune responses to HIV and approaches to designing vaccines that induce viral neutralizing and other potentially protective antibodies.

Detalles Bibliográficos
Autores principales: Montefiori, David, Sattentau, Quentin, Flores, Jorge, Esparza, José, Mascola, John
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141/
https://www.ncbi.nlm.nih.gov/pubmed/18052607
http://dx.doi.org/10.1371/journal.pmed.0040348
_version_ 1782138332762865664
author Montefiori, David
Sattentau, Quentin
Flores, Jorge
Esparza, José
Mascola, John
author_facet Montefiori, David
Sattentau, Quentin
Flores, Jorge
Esparza, José
Mascola, John
author_sort Montefiori, David
collection PubMed
description The authors discuss humoral immune responses to HIV and approaches to designing vaccines that induce viral neutralizing and other potentially protective antibodies.
format Text
id pubmed-2100141
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-21001412007-12-01 Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group Montefiori, David Sattentau, Quentin Flores, Jorge Esparza, José Mascola, John PLoS Med Policy Forum The authors discuss humoral immune responses to HIV and approaches to designing vaccines that induce viral neutralizing and other potentially protective antibodies. Public Library of Science 2007-12 2007-12-01 /pmc/articles/PMC2100141/ /pubmed/18052607 http://dx.doi.org/10.1371/journal.pmed.0040348 Text en © 2007 Montefiori et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Policy Forum
Montefiori, David
Sattentau, Quentin
Flores, Jorge
Esparza, José
Mascola, John
Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
title Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
title_full Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
title_fullStr Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
title_full_unstemmed Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
title_short Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
title_sort antibody-based hiv-1 vaccines: recent developments and future directions: a summary report from a global hiv vaccine enterprise working group
topic Policy Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100141/
https://www.ncbi.nlm.nih.gov/pubmed/18052607
http://dx.doi.org/10.1371/journal.pmed.0040348
work_keys_str_mv AT montefioridavid antibodybasedhiv1vaccinesrecentdevelopmentsandfuturedirectionsasummaryreportfromaglobalhivvaccineenterpriseworkinggroup
AT sattentauquentin antibodybasedhiv1vaccinesrecentdevelopmentsandfuturedirectionsasummaryreportfromaglobalhivvaccineenterpriseworkinggroup
AT floresjorge antibodybasedhiv1vaccinesrecentdevelopmentsandfuturedirectionsasummaryreportfromaglobalhivvaccineenterpriseworkinggroup
AT esparzajose antibodybasedhiv1vaccinesrecentdevelopmentsandfuturedirectionsasummaryreportfromaglobalhivvaccineenterpriseworkinggroup
AT mascolajohn antibodybasedhiv1vaccinesrecentdevelopmentsandfuturedirectionsasummaryreportfromaglobalhivvaccineenterpriseworkinggroup
AT antibodybasedhiv1vaccinesrecentdevelopmentsandfuturedirectionsasummaryreportfromaglobalhivvaccineenterpriseworkinggroup

Ejemplares similares